Bowsher / Carter Challenges in Prostate Cancer

2. Auflage 2008
ISBN: 978-1-4051-7177-9
Verlag: John Wiley & Sons
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)

E-Book, Englisch, 296 Seiten, E-Book

Prostate cancer continues to be a major threat to men's health, thesecond most common cancer in men, in many countries. Therefore itis increasingly important that those faced with difficult clinicalquestions make the right decisions. Since the first volume waspublished in 2000, many debates persist but new controversies havealso emerged, reflected in the chapters of this new volume. Newauthors have been recruited to give their insight into newer areasof this controversial topic.
Challenges in prostate cancer provides a series ofstate-of-the-art review articles, each of which addresses andanswers a contentious question. It includes chapters on medical andsurgical management of all stages of prostate cancer, clinicalinvestigation, epidemiology, clinical trials and basic scientificresearch and covers issues such as the genetic basis of cancer,clinical economics and influence.
The authors have used their expertise to distil the availableevidence into practical advice to be used by busy urologists intheir day-to-day practice. And as well as being an overview ofcurrent practice many chapters attempt to give insights into thefuture direction of prostate cancer research and clinicalmanagement.

Autoren/Hrsg.

Bowsher, Winsor

Carter, Adam

Inhaltsverzeichnis

List of contributors.
Part 1: Biological and Scientific Aspects.
1 Tim Lane, Jon Strefford and Tim Oliver.
An Update on Biotechnology in the Assessment of ProstateCancer.
2 Ludger Barthelmes and Christopher A. Gateley.
What Can We Learn From Breast Cancer?.
3 Bernhard Brehmer, Antonio Smakris and GerhardJakse.
New Serum Markers for Prostate Cancer.
4 Kenichiro Ishii and Simon Hayward.
The History of Tissue Recombination Technology: Current andFuture Research.
5 Malcolm Mason and John Staffurth.
Why We Cannot Use the Results of Non-Randomised Trials to InformUs About Treatment for Early Prostate Cancer?.
Part 2: Diagnosis and Evaluation.
6 Bob Djavan, Michael Dobrovits and MichaelMarberger.
Equivocal PSAResults and Free Total PSARatio.
7 Murali Varma And David Griffiths .
Equivocal Prostate Needle Biopsies.
8 Richard Clements.
Prostate Biopsy: How Many Cores and Where From?.
9 Gail Beese and Christopher Edmunds.
Counselling Patients With Early Prostate Cancer.
10 Owen Niall and Jamie Kearsley.
The Role of Pelvic Node Dissection in Prostate Cancer.
Part 3: Initial Treatment Policies.
11 Mark Wright.
Laparoscopic Radical Prostatectomy.
12 A. Goyal and W. Bowsher.
Endocrine Therapy for Prostate Cancer: the Latest.
13 Stijn De Vries, Christopher Bangma and FritzSchröder.
The Role of Conservative Policies in the Treatment of ProstateCancer.
14 Gary Deng and Barrie Cassileth.
Complementary and Alternative Therapies for Prostate Cancer.
Part 4: Monitoring Progress and SecondaryTreatment.
15 Amir Kaisary.
Radical Prostatectomy After Radical Radiotherapy.
16 Paul Jones and Neil Fenn.
Treatment of Renal Impairment Secondary to Locally AdvancedProstate Cancer.
17 Robert P. Myers, R. Houston Thompson, Stephen M. Schatzand Michael L. Blute.
Open Radical Prostatectomy: How Can Intra-operative,Peri-operative and Post-operative Complications Be Prevented?.
18 Leslie Moffat.
Documenting Prostate Cancer: Epidemiology and Treatment.
19 Steven Oliver, Rhidian Hurle and Owen Hughes.
Trends in Prostate Cancer Incidence and Mortality.
20 Jason Lester and E M Mahudson.
Chemotherapy in Prostate Cancer.
Index.
Colour plates

Über Autor(innen)

Winsor Bowsher (deceased), Department of Urology, St.Joseph's Hospital, Newport
Adam Carter, Department of Urology, Royal Gwent Hospital,Newport